CL · Full Picture

COLGATE PALMOLIVE CO — the full picture

Trailing window · 2026-05-12 to 2026-08-10

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

1. Guidance / Outlook · Guidance & outlookPriority 52
   +2.0% revenue; 2 forward row(s); quote_verified
   Colgate reaffirmed full-year 2026 guidance for net sales growth of 2% to 6% and double-digit GAAP EPS growth
2. Revenue Performance and Mix · Revenue growth & mixPriority 47
   quote_verified
   Colgate-Palmolive's oral care line contributes over 40% of its total sales.
3. Market Demand Trends · Demand, orders & backlogPriority 28
   quote_verified
   Form 144 SEC filing (Aug 6, 2026) indicates proposed sale of 4,170 common shares with aggregate market value of $389,357.94 to be sold via Merrill Lynch on the NYSE
4. AI Adoption Recognition · UnclassifiedPriority 27
   quote_verified
   Colgate is undergoing a global digital transformation, heavily investing in AI, data, and analytics to create an "agentic future"
5. Operating Margin Drivers · Operating income & profitabilityPriority 23
   quote_verified
   Q2 results showed operating margin contraction
6. Inventory Reduction · Supply chain & operationsPriority 21
   quote_verified
   Analysts on the Q2 earnings call focused on inventory reductions

Threads by pillar

Revenue & Demand Priority 49 · 2 threads

• Revenue Performance and MixPriority 47 · News
• Market Demand TrendsPriority 28 · News

Costs & Margins Priority 25 · 2 threads

• Operating Margin DriversPriority 23 · News
• Inventory ReductionPriority 21 · News

Guidance & Outlook Priority 52 · 1 thread

• Guidance / OutlookPriority 52 · News

Unclassified Priority 27 · 1 thread

• AI Adoption RecognitionPriority 27 · News

Expected impact by metric